MD Anderson and Bayer Announce Collaboration to Create Symptom Assessment Questionnaires in Clinical Trials
University of Texas MD Anderson Cancer CenterA new collaboration between Bayer and The University of Texas MD Anderson Cancer Center will go straight to the patients to learn how certain investigational new drugs affect them. The project will involve the use of questionnaires to assess how a drug may impact a patient’s disease-related symptoms.